Healthcare

Global Argatroban Market by Manufacturers, Regions, Type and Application, Forecast to 2023

  • GLO2636947
  • 128 Pages
  • July 2018
  • Healthcare
Download Sample    Get Discount   
 
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.

Scope of the Report:

This report focuses on the Argatroban in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

In the last several years, global market of Argatroban Industry decreased with the average production growth rate about -15%. In 2015, global capacity of Argatroban reduced to 34786 grams

from 65183 grams since 2011. It is predicted that the argatroban demand will continue to decrease with a average growth rate of -9% in the coming five years.

Japan is the still largest supplier of argatroban with the production market share of 35% and the consumption market share of 22% in 2015.

The price of argatroban is relatively expensive. The largest consumers are developed countries with high income. USA occupied a market share of 34%. The second place is Europe, following North America with the consumption market share of 22% in 2015.

China has few companies entering the market with production share of only 8%, and demand cannot be satisfied with supply. Large quantities of argatroban have to be imported.

Intially, compared with hirudin and heparin, the therapeutic dose has little effect on platelet, no antigen and strong antithrombotic effect. The sale value has reached 190 million USA dollars in 2008. But because of its narrow therapeutic area, uncertain factors on human’s bodies and fierce competition from other substitutes, it sales far less than other thrombin inhibitor. The value reduced to 101 million USA dollars in 2015.

The worldwide market for Argatroban is expected to grow at a CAGR of roughly -14.9% over the next five years, will reach 32 million US$ in 2023, from 84 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Pfizer, Inc

SANDOZ

GlaxoSmithKline Plc

fresenius-kabi

Eagle Pharmaceuticals, Inc

Mitsubishi Tanabe Pharma

Teva Pharmaceutical Industries Ltd

WEST-WARD,INC

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Argatroban Powder

Argatroban Injection

Market Segment by Applications, can be divided into

Heparin-induced thrombocytopenia (HIT)

Percutaneous Coronary Intervention

Cerebral arterial thrombosis

There are 15 Chapters to deeply display the global Argatroban market.

Chapter 1, to describe Argatroban Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Argatroban, with sales, revenue, and price of Argatroban, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Argatroban, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Argatroban market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Argatroban sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Argatroban Introduction

1.2 Market Analysis by Type

1.2.1 Argatroban Powder

1.2.2 Argatroban Injection

1.3 Market Analysis by Applications

1.3.1 Heparin-induced thrombocytopenia (HIT)

1.3.2 Percutaneous Coronary Intervention

1.3.3 Cerebral arterial thrombosis

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer, Inc

2.1.1 Business Overview

2.1.2 Argatroban Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 SANDOZ

2.2.1 Business Overview

2.2.2 Argatroban Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 SANDOZ Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline Plc

2.3.1 Business Overview

2.3.2 Argatroban Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline Plc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 fresenius-kabi

2.4.1 Business Overview

2.4.2 Argatroban Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 fresenius-kabi Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Eagle Pharmaceuticals, Inc

2.5.1 Business Overview

2.5.2 Argatroban Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Eagle Pharmaceuticals, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Mitsubishi Tanabe Pharma

2.6.1 Business Overview

2.6.2 Argatroban Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Mitsubishi Tanabe Pharma Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Teva Pharmaceutical Industries Ltd

2.7.1 Business Overview

2.7.2 Argatroban Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Teva Pharmaceutical Industries Ltd Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 WEST-WARD,INC

2.8.1 Business Overview

2.8.2 Argatroban Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 WEST-WARD,INC Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Argatroban Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Argatroban Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Argatroban Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Argatroban Manufacturer Market Share in 2017

3.3.2 Top 6 Argatroban Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Argatroban Market Analysis by Regions

4.1 Global Argatroban Sales, Revenue and Market Share by Regions

4.1.1 Global Argatroban Sales and Market Share by Regions (2013-2018)

4.1.2 Global Argatroban Revenue and Market Share by Regions (2013-2018)

4.2 North America Argatroban Sales and Growth Rate (2013-2018)

4.3 Europe Argatroban Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Argatroban Sales and Growth Rate (2013-2018)

4.5 South America Argatroban Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Argatroban Sales and Growth Rate (2013-2018)

5 North America Argatroban by Countries

5.1 North America Argatroban Sales, Revenue and Market Share by Countries

5.1.1 North America Argatroban Sales and Market Share by Countries (2013-2018)

5.1.2 North America Argatroban Revenue and Market Share by Countries (2013-2018)

5.2 United States Argatroban Sales and Growth Rate (2013-2018)

5.3 Canada Argatroban Sales and Growth Rate (2013-2018)

5.4 Mexico Argatroban Sales and Growth Rate (2013-2018)

6 Europe Argatroban by Countries

6.1 Europe Argatroban Sales, Revenue and Market Share by Countries

6.1.1 Europe Argatroban Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Argatroban Revenue and Market Share by Countries (2013-2018)

6.2 Germany Argatroban Sales and Growth Rate (2013-2018)

6.3 UK Argatroban Sales and Growth Rate (2013-2018)

6.4 France Argatroban Sales and Growth Rate (2013-2018)

6.5 Russia Argatroban Sales and Growth Rate (2013-2018)

6.6 Italy Argatroban Sales and Growth Rate (2013-2018)

7 Asia-Pacific Argatroban by Countries

7.1 Asia-Pacific Argatroban Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Argatroban Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Argatroban Revenue and Market Share by Countries (2013-2018)

7.2 China Argatroban Sales and Growth Rate (2013-2018)

7.3 Japan Argatroban Sales and Growth Rate (2013-2018)

7.4 Korea Argatroban Sales and Growth Rate (2013-2018)

7.5 India Argatroban Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Argatroban Sales and Growth Rate (2013-2018)

8 South America Argatroban by Countries

8.1 South America Argatroban Sales, Revenue and Market Share by Countries

8.1.1 South America Argatroban Sales and Market Share by Countries (2013-2018)

8.1.2 South America Argatroban Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Argatroban Sales and Growth Rate (2013-2018)

8.3 Argentina Argatroban Sales and Growth Rate (2013-2018)

8.4 Colombia Argatroban Sales and Growth Rate (2013-2018)

9 Middle East and Africa Argatroban by Countries

9.1 Middle East and Africa Argatroban Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Argatroban Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Argatroban Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Argatroban Sales and Growth Rate (2013-2018)

9.3 UAE Argatroban Sales and Growth Rate (2013-2018)

9.4 Egypt Argatroban Sales and Growth Rate (2013-2018)

9.5 Nigeria Argatroban Sales and Growth Rate (2013-2018)

9.6 South Africa Argatroban Sales and Growth Rate (2013-2018)

10 Global Argatroban Market Segment by Type

10.1 Global Argatroban Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Argatroban Sales and Market Share by Type (2013-2018)

10.1.2 Global Argatroban Revenue and Market Share by Type (2013-2018)

10.2 Argatroban Powder Sales Growth and Price

10.2.1 Global Argatroban Powder Sales Growth (2013-2018)

10.2.2 Global Argatroban Powder Price (2013-2018)

10.3 Argatroban Injection Sales Growth and Price

10.3.1 Global Argatroban Injection Sales Growth (2013-2018)

10.3.2 Global Argatroban Injection Price (2013-2018)

11 Global Argatroban Market Segment by Application

11.1 Global Argatroban Sales Market Share by Application (2013-2018)

11.2 Heparin-induced thrombocytopenia (HIT) Sales Growth (2013-2018)

11.3 Percutaneous Coronary Intervention Sales Growth (2013-2018)

11.4 Cerebral arterial thrombosis Sales Growth (2013-2018)

12 Argatroban Market Forecast (2018-2023)

12.1 Global Argatroban Sales, Revenue and Growth Rate (2018-2023)

12.2 Argatroban Market Forecast by Regions (2018-2023)

12.2.1 North America Argatroban Market Forecast (2018-2023)

12.2.2 Europe Argatroban Market Forecast (2018-2023)

12.2.3 Asia-Pacific Argatroban Market Forecast (2018-2023)

12.2.4 South America Argatroban Market Forecast (2018-2023)

12.2.5 Middle East and Africa Argatroban Market Forecast (2018-2023)

12.3 Argatroban Market Forecast by Type (2018-2023)

12.3.1 Global Argatroban Sales Forecast by Type (2018-2023)

12.3.2 Global Argatroban Market Share Forecast by Type (2018-2023)

12.4 Argatroban Market Forecast by Application (2018-2023)

12.4.1 Global Argatroban Sales Forecast by Application (2018-2023)

12.4.2 Global Argatroban Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Argatroban Picture

Table Product Specifications of Argatroban

Figure Global Sales Market Share of Argatroban by Types in 2017

Table Argatroban Types for Major Manufacturers

Figure Argatroban Powder Picture

Figure Argatroban Injection Picture

Figure Argatroban Sales Market Share by Applications in 2017

Figure Heparin-induced thrombocytopenia (HIT) Picture

Figure Percutaneous Coronary Intervention Picture

Figure Cerebral arterial thrombosis Picture

Figure United States Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure France Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure UK Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure China Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure India Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Argatroban Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Argatroban Revenue (Value) and Growth Rate (2013-2023)

Table Pfizer, Inc Basic Information, Manufacturing Base and Competitors

Table Pfizer, Inc Argatroban Type and Applications

Table Pfizer, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table SANDOZ Basic Information, Manufacturing Base and Competitors

Table SANDOZ Argatroban Type and Applications

Table SANDOZ Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Plc Argatroban Type and Applications

Table GlaxoSmithKline Plc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table fresenius-kabi Basic Information, Manufacturing Base and Competitors

Table fresenius-kabi Argatroban Type and Applications

Table fresenius-kabi Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eagle Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors

Table Eagle Pharmaceuticals, Inc Argatroban Type and Applications

Table Eagle Pharmaceuticals, Inc Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors

Table Mitsubishi Tanabe Pharma Argatroban Type and Applications

Table Mitsubishi Tanabe Pharma Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors

Table Teva Pharmaceutical Industries Ltd Argatroban Type and Applications

Table Teva Pharmaceutical Industries Ltd Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table WEST-WARD,INC Basic Information, Manufacturing Base and Competitors

Table WEST-WARD,INC Argatroban Type and Applications

Table WEST-WARD,INC Argatroban Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Argatroban Sales by Manufacturer (2016-2017)

Figure Global Argatroban Sales Market Share by Manufacturer in 2016

Figure Global Argatroban Sales Market Share by Manufacturer in 2017

Table Global Argatroban Revenue by Manufacturer (2016-2017)

Figure Global Argatroban Revenue Market Share by Manufacturer in 2016

Figure Global Argatroban Revenue Market Share by Manufacturer in 2017

Figure Top 3 Argatroban Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Argatroban Manufacturer (Revenue) Market Share in 2017

Figure Global Argatroban Sales and Growth Rate (2013-2018)

Figure Global Argatroban Revenue and Growth Rate (2013-2018)

Table Global Argatroban Sales by Regions (2013-2018)

Table Global Argatroban Sales Market Share by Regions (2013-2018)

Table Global Argatroban Revenue by Regions (2013-2018)

Figure Global Argatroban Revenue Market Share by Regions in 2013

Figure Global Argatroban Revenue Market Share by Regions in 2017

Figure North America Argatroban Sales and Growth Rate (2013-2018)

Figure Europe Argatroban Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Argatroban Sales and Growth Rate (2013-2018)

Figure South America Argatroban Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Argatroban Sales and Growth Rate (2013-2018)

Figure North America Argatroban Revenue and Growth Rate (2013-2018)

Table North America Argatroban Sales by Countries (2013-2018)

Table North America Argatroban Sales Market Share by Countries (2013-2018)

Figure North America Argatroban Sales Market Share by Countries in 2013

Figure North America Argatroban Sales Market Share by Countries in 2017

Table North America Argatroban Revenue by Countries (2013-2018)

Table North America Argatroban Revenue Market Share by Countries (2013-2018)

Figure North America Argatroban Revenue Market Share by Countries in 2013

Figure North America Argatroban Revenue Market Share by Countries in 2017

Figure United States Argatroban Sales and Growth Rate (2013-2018)

Figure Canada Argatroban Sales and Growth Rate (2013-2018)

Figure Mexico Argatroban Sales and Growth Rate (2013-2018)

Figure Europe Argatroban Revenue and Growth Rate (2013-2018)

Table Europe Argatroban Sales by Countries (2013-2018)

Table Europe Argatroban Sales Market Share by Countries (2013-2018)

Table Europe Argatroban Revenue by Countries (2013-2018)

Figure Europe Argatroban Revenue Market Share by Countries in 2016

Figure Europe Argatroban Revenue Market Share by Countries in 2017

Figure Germany Argatroban Sales and Growth Rate (2013-2018)

Figure UK Argatroban Sales and Growth Rate (2013-2018)

Figure France Argatroban Sales and Growth Rate (2013-2018)

Figure Russia Argatroban Sales and Growth Rate (2013-2018)

Figure Italy Argatroban Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Argatroban Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Argatroban Sales by Countries (2013-2018)

Table Asia-Pacific Argatroban Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Argatroban Sales Market Share by Countries 2017

Table Asia-Pacific Argatroban Revenue by Countries (2013-2018)

Figure Asia-Pacific Argatroban Revenue Market Share by Countries 2017

Figure China Argatroban Sales and Growth Rate (2013-2018)

Figure Japan Argatroban Sales and Growth Rate (2013-2018)

Figure Korea Argatroban Sales and Growth Rate (2013-2018)

Figure India Argatroban Sales and Growth Rate (2013-2018)

Figure Southeast Asia Argatroban Sales and Growth Rate (2013-2018)

Figure South America Argatroban Revenue and Growth Rate (2013-2018)

Table South America Argatroban Sales by Countries (2013-2018)

Table South America Argatroban Sales Market Share by Countries (2013-2018)

Figure South America Argatroban Sales Market Share by Countries in 2017

Table South America Argatroban Revenue by Countries (2013-2018)

Table South America Argatroban Revenue Market Share by Countries (2013-2018)

Figure South America Argatroban Revenue Market Share by Countries in 2017

Figure Brazil Argatroban Sales and Growth Rate (2013-2018)

Figure Argentina Argatroban Sales and Growth Rate (2013-2018)

Figure Colombia Argatroban Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Argatroban Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Argatroban Sales by Countries (2013-2018)

Table Middle East and Africa Argatroban Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Argatroban Sales Market Share by Countries in 2017

Table Middle East and Africa Argatroban Revenue by Countries (2013-2018)

Table Middle East and Africa Argatroban Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Argatroban Revenue Market Share by Countries in 2013

Figure Middle East and Africa Argatroban Revenue Market Share by Countries in 2017

Figure Saudi Arabia Argatroban Sales and Growth Rate (2013-2018)

Figure UAE Argatroban Sales and Growth Rate (2013-2018)

Figure Egypt Argatroban Sales and Growth Rate (2013-2018)

Figure Nigeria Argatroban Sales and Growth Rate (2013-2018)

Figure South Africa Argatroban Sales and Growth Rate (2013-2018)

Table Global Argatroban Sales by Type (2013-2018)

Table Global Argatroban Sales Share by Type (2013-2018)

Table Global Argatroban Revenue by Type (2013-2018)

Table Global Argatroban Revenue Share by Type (2013-2018)

Figure Global Argatroban Powder Sales Growth (2013-2018)

Figure Global Argatroban Powder Price (2013-2018)

Figure Global Argatroban Injection Sales Growth (2013-2018)

Figure Global Argatroban Injection Price (2013-2018)

Table Global Argatroban Sales by Application (2013-2018)

Table Global Argatroban Sales Share by Application (2013-2018)

Figure Global Percutaneous Coronary Intervention Sales Growth (2013-2018)

Figure Global Cerebral arterial thrombosis Sales Growth (2013-2018)

Figure Global Argatroban Sales, Revenue and Growth Rate (2018-2023)

Table Global Argatroban Sales Forecast by Regions (2018-2023)

Table Global Argatroban Market Share Forecast by Regions (2018-2023)

Figure North America Sales Argatroban Market Forecast (2018-2023)

Figure Europe Sales Argatroban Market Forecast (2018-2023)

Figure Asia-Pacific Sales Argatroban Market Forecast (2018-2023)

Figure South America Sales Argatroban Market Forecast (2018-2023)

Figure Middle East and Africa Sales Argatroban Market Forecast (2018-2023)

Table Global Argatroban Sales Forecast by Type (2018-2023)

Table Global Argatroban Market Share Forecast by Type (2018-2023)

Table Global Argatroban Sales Forecast by Application (2018-2023)

Table Global Argatroban Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370